You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sodium Glucose Co Transporter 2 inhibitors

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glucose Metabolism Disorders, Diabetes, Type 2, Hypoglycemic Agents Trial in Karachi (Empagliflozin 10 MG,

Recruiting
  • Glucose Metabolism Disorders
  • +3 more
  • Empagliflozin 10 MG
  • Insulin+Metformin+DPP4 inhibitor (DPP4I)
  • Karachi, Pakistan
    SINA Shireen Jinnah colony
Nov 28, 2023

Glomerulonephritis, Proteinuria Trial in Cairo (Empagliflozin 25 MG, )

Completed
  • Glomerulonephritis
  • Proteinuria
  • Empagliflozin 25 MG
  • placebo
  • Cairo, Egypt
    Cairo university hospitals
Mar 7, 2022

CHF Trial in Moscow (Standard list of drugs used for acute decompensation of CHF (loop diuretics, vasodilators, digoxin,

Recruiting
  • Congestive Heart Failure
  • Standard list of drugs used for acute decompensation of CHF (loop diuretics, vasodilators, digoxin, inotropic agents, vasopressors), plus dapagliflozin (Forxiga; MP-002596)
  • Moscow, Russian Federation
  • +1 more
Mar 15, 2022

Type 2 Diabetes Trial in Seoul (TZD group, SGLT-2 group)

Completed
  • Type 2 Diabetes Mellitus
  • TZD group
  • SGLT-2 group
  • Seoul, Korea, Republic of
    Division of Endocrinology and Metabolism, Department of Internal
May 3, 2021

Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)

Not yet recruiting
  • Fatty Liver, Nonalcoholic
  • SGLT2 inhibitor
  • (no location specified)
Oct 31, 2023

Liver Cirrhosis, Cirrhosis, Ascites Trial in Redwood City (Empagliflozin 10 MG)

Recruiting
  • Liver Cirrhosis
  • +4 more
  • Empagliflozin 10 MG
  • Redwood City, California
    Stanford University Digestive Health Clinic
Mar 21, 2022

Acute Kidney Injury, Kidney Failure, Sodium Glucose Cotransporter-2 Inhibitors Trial in Newtown (SGLT2 inhibitor or matched )

Not yet recruiting
  • Acute Kidney Injury
  • +2 more
  • SGLT2 inhibitor or matched placebo
  • Newtown, New South Wales, Australia
    The George Institute for Global Health
Jul 19, 2022

Diabetes, Cardiovascular Diseases Trial in Singapore (Renin-angiotensin-aldosterone system inhibitors, Beta blocker, SGLT2

Recruiting
  • Diabetes Mellitus
  • Cardiovascular Diseases
  • Renin-angiotensin-aldosterone system inhibitors
  • +2 more
  • Singapore, Singapore
    Singapore General Hospital (SGH)
Apr 28, 2021

Heart Failure With Reduced Ejection Fraction Trial in Porto (Sacubitril-valsartan, SGLT2 inhibitor)

Recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Porto, Portugal
  • +3 more
Aug 9, 2023

Type2 Diabetes, Heart Failure With Preserved Ejection Fraction Trial in San Antonio (Empagliflozin 25 MG, Placebo)

Recruiting
  • Type2 Diabetes
  • Heart Failure With Preserved Ejection Fraction
  • Empagliflozin 25 MG
  • Placebo
  • San Antonio, Texas
  • +1 more
Jan 21, 2023

Called FLAMINgO to Learn More About Treatment Combination of

Active, not recruiting
  • Chronic Kidney Disease
  • Type 2 Diabetes
  • Finerenone (Kerendia, BAY94-8862)
  • Sodium-glucose cotransporter-2 inhibitors (SGLT2i)
  • Whippany, New Jersey
    Bayer
Jan 19, 2023

Acute Heart Failure Trial in Cairo (Dapagliflozin 10mg Tab)

Active, not recruiting
  • Acute Heart Failure
  • Dapagliflozin 10mg Tab
  • Cairo, Egypt
    Kasr Al-Ainy Medical School
Aug 24, 2023

Myocardial Infarction Trial in Shibin Al Kawm (Dapagliflozin 10mg Tab, Placebo)

Recruiting
  • Myocardial Infarction
  • Dapagliflozin 10mg Tab
  • Placebo
  • Shibīn Al Kawm, Menofia, Egypt
    Mohammad Soliman
Aug 18, 2023

IgA Nephropathy, Immunoglobulin A Nephropathy Trial (Atrasentan, Placebo)

Not yet recruiting
  • IgA Nephropathy
  • Immunoglobulin A Nephropathy
  • (no location specified)
Apr 27, 2023

Semaglutide in Type 2 Diabetes - A Cohort Study Based on Nordic

Enrolling by invitation
  • Diabetes Mellitus, Type 2
  • Odense, Denmark
    Novo Nordisk Investigational Site
Nov 30, 2022

Heart Failure Trial in Gallup (EHR-based GDMT Optimization)

Not yet recruiting
  • Heart Failure
  • EHR-based GDMT Optimization
  • Gallup, New Mexico
    Gallup Indian Medical Center
Mar 17, 2023

Deformation Imaging by Strain in Chronic Heart Failure Over

Recruiting
  • Sodium-GLucose coTransporter-2 Inhibitors
  • Heart Failure With Reduced Ejection Fraction
  • Sodium-GLucose coTransporter-2 inhibitors
  • Siena, Italy
    UOC Diagnostica Cardiovascolare, AOU Senese Policlinico Le Scott
May 5, 2022

Heart Failure, Cardiomyopathy, Dilated, Cardiomyopathies Trial (Other)

Not yet recruiting
  • Heart Failure
  • +3 more
  • (no location specified)
Oct 17, 2023

Cancer Trial (Empagliflozin 10 MG)

Not yet recruiting
  • Cancer
  • Empagliflozin 10 MG
  • (no location specified)
Oct 22, 2023

Fatty Liver Disease Trial (Empagliflozin 10 MG)

Not yet recruiting
  • Fatty Liver Disease
  • Empagliflozin 10 MG
  • (no location specified)
Jan 19, 2023

Non-alcoholic Fatty Liver Disease Trial in Kanazawa (Tofogliflozin, Glimepiride)

Completed
  • Non-alcoholic Fatty Liver Disease
  • Kanazawa, Ishikawa, Japan
    Kanazawa University Graduate School of Medical Sciences
Jun 30, 2021

Heart Failure, Type 2 Diabetes Trial in Dundee (Empagliflozin 25mg, Placebo oral capsule, Frusemide)

Completed
Has Results
  • Heart Failure
  • Type 2 Diabetes Mellitus
  • Empagliflozin 25mg
  • +2 more
  • Dundee, Angus, United Kingdom
    University of Dundee, Ninewells Hospital and Medical School
Jun 22, 2021

Patients With Type 2 Diabetes Mellitus (CVD-RNDR)

Completed
  • Type 2 Diabetes
    • Moscow, Russian Federation
      Research site
    Jun 6, 2019

    Heart Failure, Type 2 Diabetes, Chronic Kidney Diseases Trial (Virtual Consult Intervention)

    Not yet recruiting
    • Heart Failure
    • +2 more
    • Virtual Consult Intervention
    • (no location specified)
    Mar 21, 2023

    Acute Heart Failure Trial in Japan (Empagliflozin 10 MG, Placebo)

    Recruiting
    • Acute Heart Failure
    • Empagliflozin 10 MG
    • Placebo
    • Anjo, Aichi, Japan
    • +50 more
    Jan 21, 2023